Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-285634
Filing Date
2021-09-28
Accepted
2021-09-28 17:16:35
Documents
17
Period of Report
2021-05-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d236050d10ka.htm   iXBRL 10-K/A 572154
2 EX-31.3 d236050dex313.htm EX-31.3 4943
3 EX-31.4 d236050dex314.htm EX-31.4 4847
9 GRAPHIC g236050g0928041524176.jpg GRAPHIC 1901
  Complete submission text file 0001193125-21-285634.txt   806553

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cydy-20210531.xsd EX-101.SCH 4853
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20210531_cal.xml EX-101.CAL 675
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20210531_def.xml EX-101.DEF 1680
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20210531_lab.xml EX-101.LAB 18636
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20210531_pre.xml EX-101.PRE 14748
10 EXTRACTED XBRL INSTANCE DOCUMENT d236050d10ka_htm.xml XML 6882
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-K/A | Act: 34 | File No.: 000-49908 | Film No.: 211288265
SIC: 2834 Pharmaceutical Preparations